Inventor
Sangdon Han
Inventor
San Diego, CA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07CAcyclic or carbocyclic compounds4%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
10,766,877Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof202010,696,689Somatostatin modulators and uses thereof202010,632,134Cannabinoid receptor modulators202010,604,507Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof202010,562,884Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof202010,351,547Somatostatin modulators and uses thereof201910,183,930Crystalline forms and processes for the preparation of cannabinoid receptor modulators20199,987,252Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto20189,944,606Cannabinoid receptor modulators20189,902,703'Somatostatin modulators and uses thereof'20189,896,432'Somatostatin modulators and uses thereof'20189,867,822'Cannabinoid receptor modulators'20189,597,340'Cannabinoid receptor modulators'20179,522,133'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'20169,492,447'Cannabinoid receptor modulators'20169,458,136'Crystalline forms and processes for the preparation of cannabinoid receptor modulators'20169,328,107'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20169,126,932'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'2015RE045336'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20158,778,950'Cannabinoid receptor modulators'20148,664,258'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,580,841'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'20138,148,417'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2020Patents assigned to ARENA PHARM INC (16)· patent assignee history
2012–2018Patents assigned to HAN SANGDON (7)· patent assignee history
2012–2020Based in San Diego, CA, US· patent location history
2013–2018Patents assigned to JONES ROBERT M (5)· patent assignee history
2013–2018Patents assigned to ZHU XIUWEN (4)· patent assignee history
2018–2020Patents assigned to CRINETICS PHARMACEUTICALS INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 16 | 2012–2020 |
| CRINETICS PHARMACEUTICALS INC | 7 | 2018–2020 |
| HAN SANGDONself | 7 | 2012–2018 |
| JONES ROBERT M | 5 | 2013–2018 |
| ZHU XIUWEN | 4 | 2013–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 23 | 2012–2020 |